MedTrace Logo

Study for the RevLite Laser System for Facial Solar Lentigines

NCT02110108 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2021-11-30

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to evaluate the effects of the Revlite Laser System for treatment of facial solar lentigines

Conditions

  • Facial Solar Lentigines

Interventions

DEVICE

Revlite Laser System

Revlite Laser System for the Treatment of Facial Solar Lentigines

Sponsors & Collaborators

  • Cynosure, Inc.

    lead INDUSTRY

Principal Investigators

  • Patricia Krantz · Cynosure, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
DEVICE_FEASIBILITY
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2015-02-28
Completion
2015-02-28
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02110108 on ClinicalTrials.gov